Lawmakers might address drug shortages in FDA user-fee bill

Source: BIO SmartBrief/Reuters
House lawmakers might add language to the Prescription Drug User Fee Act to require the FDA to accelerate review of applications from companies that want to change production to address a drug shortage. Lawmakers also want drugmakers to notify the FDA of potential shortages. Reuters (1/31)

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: